Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence. The FDA's September 22 direct final rule, which swaps ...
New position paper argues that fragmented data, broken scientific handoffs, and outdated tech transfer models are turning Chemistry, Manufacturing, Controls (CMC) into a billion-dollar bottleneck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results